Literature DB >> 9475834

New approaches to reduce Staphylococcus aureus nosocomial infection rates: treating S. aureus nasal carriage.

T M Perl1, J E Golub.   

Abstract

BACKGROUND: Nosocomial infections cause significant patient morbidity and mortality. The 2.5 million nosocomial infections that occur each year cost the US healthcare system $5 million to $10 million. Staphylococcus aureus has long been recognized as an important pathogen in human disease and is the most common cause of nosocomial infections.
OBJECTIVE: To describe the epidemiology of S. aureus nosocomial infections that are attributable to patients' endogenous colonization. DATA SOURCES: Review of the English-language literature and a MEDLINE search (as of September 1997). DATA SYNTHESIS: The ecologic niche of S. aureus is the anterior nares. The prevalence of S. aureus nasal carriage is approximately 20-25%, but varies among different populations, and is influenced by age, underlying illness, race, certain behaviors, and the environment in which the person lives or works. The link between S. aureus nasal carriage and development of subsequent S. aureus infections has been established in patients on hemodialysis, on continuous ambulatory peritoneal dialysis, and those undergoing surgery. S. aureus nasal carriers have a two-to tenfold increased risk of developing S. aureus surgical site or intravenous catheter infections. Thirty percent of 100% of S. aureus infections are due to endogenous flora and infecting strains were genetically identical to nasal strains. Three treatment strategies may eliminate nasal carriage: locally applied antibiotics or disinfectants, systemic antibiotics, and bacterial interference. Among these strategies, locally applied or systemic antibiotics are most commonly used. Nasal ointments or sprays and oral antibiotics have variable efficacy and their use frequently results in antimicrobial resistance among S. aureus strains. Of the commonly used agents, mupirocin (pseudomonic acid) ointment has been shown to be 97% effective in reducing S. aureus nasal carriage. However, resistance occurs when the ointment has been applied for a prolonged period over large surface areas.
CONCLUSIONS: Given the importance of S. aureus nosocomial infections and the increased risk of S. aureus nasal carriage in patients with nosocomial infections, investigators need to study cost-effective strategies to prevent certain types of nosocomial infections or nosocomial infections that occur in specific settings. One potential strategy is to decrease S. aureus nasal carriage among certain patient populations.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9475834     DOI: 10.1177/106002809803200104

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  30 in total

1.  Reducing surgical site infections: a review.

Authors:  David E Reichman; James A Greenberg
Journal:  Rev Obstet Gynecol       Date:  2009

Review 2.  Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

3.  Prevalence of MRSA colonization in an adult urban Indian population undergoing orthopaedic surgery.

Authors:  Sanjay Agarwala; Dnyanesh Lad; Vikas Agashe; Anshul Sobti
Journal:  J Clin Orthop Trauma       Date:  2015-09-11

Review 4.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  What is the prevalence of MRSA colonization in elective spine cases?

Authors:  Antonia F Chen; Srinivas Chivukula; Lloydine J Jacobs; Matthew W Tetreault; Joon Y Lee
Journal:  Clin Orthop Relat Res       Date:  2012-10       Impact factor: 4.176

6.  Establishment of a superficial skin infection model in mice by using Staphylococcus aureus and Streptococcus pyogenes.

Authors:  Elisabeth Kugelberg; Tobias Norström; Thomas K Petersen; Tore Duvold; Dan I Andersson; Diarmaid Hughes
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

7.  Routine pre-cesarean Staphylococcus aureus screening and decolonization: a cost-effectiveness analysis.

Authors:  Bruce Y Lee; Ann E Wiringa; Elizabeth A Mitgang; Sarah M McGlone; Abena N Afriyie; Yeohan Song; Richard H Beigi
Journal:  Am J Manag Care       Date:  2011-10       Impact factor: 2.229

8.  A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5mg/g viscosified gel formulation versus a modified formulation.

Authors:  George A Yendewa; J McLeod Griffiss; Michael R Jacobs; Scott A Fulton; Mary Ann O'Riordan; Wesley A Gray; Howard M Proskin; Peter Winkle; Robert A Salata
Journal:  J Glob Antimicrob Resist       Date:  2019-10-07       Impact factor: 4.035

9.  Prior inpatient admission increases the risk of post-operative infection in hepatobiliary and pancreatic surgery.

Authors:  Zachary M Dong; Alexis P Chidi; Julie Goswami; Katrina Han; Richard L Simmons; Matthew R Rosengart; Allan Tsung
Journal:  HPB (Oxford)       Date:  2015-09-03       Impact factor: 3.647

10.  A preoperative decolonization protocol for staphylococcus aureus prevents orthopaedic infections.

Authors:  Nalini Rao; Barbara Cannella; Lawrence S Crossett; A J Yates; Richard McGough
Journal:  Clin Orthop Relat Res       Date:  2008-04-11       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.